Jane Street
ORMP icon

Jane Street’s Oramed Pharmaceuticals ORMP Stock Holding History

Jane Street’s Portfolio ORMP Stock Details ORMP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-29,900
Closed -$360K – 9682
2022
Q4 		$360K Buy
+29,900
New +$232K ﹤0.01% 6701
2022
Q2 		– Sell
-12,800
Closed -$111K – 10525
2022
Q1 		$111K Sell
12,800
-8,400
-40% -$86.1K ﹤0.01% 9404
2021
Q4 		$303K Sell
21,200
-27,100
-56% -$567K ﹤0.01% 8150
2021
Q3 		$1.06M Buy
48,300
+22,900
+90% +$390K ﹤0.01% 5790
2021
Q2 		$340K Buy
+25,400
New +$291K ﹤0.01% 7933

Other funds holding ORMP

BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
AF
Aquamarine Financial George Town $1.37B AUM
Mercer Global Advisors
Mercer Global Advisors Denver, Colorado $67.6B AUM 18.3% 1-Year Est. Return
GIA
Gem Investment Advisors Teaneck, New Jersey $102M AUM
M
Murchinson Toronto, Ontario, Canada $791M AUM 68.08% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Jane Street's ORMP Position: Q1 2026 in Review

Jane Street reduced its Oramed Pharmaceuticals (ORMP) stake by 33% in Q1 2026, selling an estimated $87.3K and leaving 52,540 shares worth $179K. The position accounts for ﹤0.01% of the portfolio, ranked #10256.

Jane Street first reported a position in ORMP in Q1 2014 and has held it in 27 quarters since. The position peaked at $1.6M in Q4 2022. 64 funds tracked by Wall St. Rank hold ORMP as of Q1 2026.

  • Jane Street held 52,540 shares of Oramed Pharmaceuticals worth $179K as of Q1 2026.
  • Jane Street sold 25,719 Oramed Pharmaceuticals shares in Q1 2026, an estimated $87.3K.
  • Oramed Pharmaceuticals made up ﹤0.01% of Jane Street's portfolio in Q1 2026, its #10256 holding.
  • Jane Street first reported a position in Oramed Pharmaceuticals in Q1 2014 and has held it in 27 quarters since.
  • Jane Street's Oramed Pharmaceuticals position peaked at $1.6M in Q4 2022.
  • 64 funds tracked by Wall St. Rank held Oramed Pharmaceuticals as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.